George C. Rovnyak
Bristol-Myers Squibb (United States)(US)
Publications by Year
Research Areas
Synthesis and Biological Evaluation, Synthesis of heterocyclic compounds, Cyclopropane Reaction Mechanisms, Asymmetric Synthesis and Catalysis, Synthesis and Characterization of Heterocyclic Compounds
Most-Cited Works
- → Calcium Entry Blockers and Activators: Conformational and Structural Determinants of Dihydropyrimidine Calcium Channel Modulators(1995)549 cited
- → Dihydropyrimidine calcium channel blockers. 4. Basic 3-substituted-4-aryl-1,4-dihydropyrimidine-5-carboxylic acid esters. Potent antihypertensive agents(1992)450 cited
- → Dihydropyrimidine calcium channel blockers. II. 3-Substituted-4-aryl-1,4-dihydro-6-methyl-5-pyrimidinecarboxylic acid esters as potent mimics of dihydropyridines(1990)376 cited
- → Substituted 1,4-dihydropyrimidines. 3. Synthesis of selectively functionalized 2-hetero-1,4-dihydropyrimidines(1989)364 cited
- → Dihydropyrimidine calcium channel blockers: 2-heterosubstituted 4-aryl-1,4-dihydro-6-methyl-5-pyrimidinecarboxylic acid esters as potent mimics of dihydropyridines(1990)283 cited
- → Angiotensin-converting enzyme inhibitors. Mercaptan, carboxyalkyl dipeptide, and phosphinic acid inhibitors incorporating 4-substituted prolines(1988)163 cited
- → Cardioselective Antiischemic ATP-Sensitive Potassium Channel (KATP) Openers. 5. Identification of 4-(N-Aryl)-Substituted Benzopyran Derivatives with High Selectivity(1997)67 cited
- → Synthesis and SAR of pyrrolotriazine-4-one based Eg5 inhibitors(2006)51 cited
- → Studies directed toward ascertaining the active conformation of 1,4-dihydropyridine calcium entry blockers(1988)50 cited
- → Benzazepinone calcium channel blockers. 4. Structure-activity overview and intracellular binding site(1992)44 cited